Polycythemia Vera Medications

Mimrylo is part of the Hepcidin Mimetics class and treats Polycythemia Vera. Hepcidin mimetics are used to treat erythrocytosis, or a high number a red blood cells. They work by mimicing the hormone hepcidin to help regulate iron levels within the body. Mimrylo is only available as a brand name drug.

ROPEGINTERFERON ALFA-2B treats blood and bone marrow cancers. It works by slowing down the growth of cancer cells.

The average list price of Jakafi (Ruxolitinib) is $17,150.00, but your out of pocket cost will likely be less if you have insurance. Jakafi is covered by some Medicare and insurance plans. This drug is also a limited distribution drug, meaning it is not available at retail pharmacies. Refer to the Key Takeaways for additional information on Jakafi and check our savings tips for other ways to reduce your cost. A generic version of Jakafi is not yet available.

Jakafi XR is part of the JAK Inhibitors class and treats Myelofibrosis, Chronic Graft Versus-Host Disease and Polycythemia Vera. JAK inhibitors are used to treat several different conditions such as rheumatoid arthritis, ulcerative colitis, eczema, and myelofibrosis. They work by blocking the attachment of proteins to their receptors so that the immune system does not over produce inflammation. Jakafi XR is only available as a brand name drug.